CeriBell Gross Margin 2024-2025 | CBLL
Current and historical gross margin for CeriBell (CBLL) over the last 10 years. The current gross profit margin for CeriBell as of September 30, 2025 is %.
| CeriBell Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2025-09-30 | $0.08B | $0.07B | 87.95% |
| 2025-06-30 | $0.08B | $0.07B | 88.31% |
| 2025-03-31 | $0.07B | $0.06B | 87.32% |
| 2024-12-31 | $0.07B | $0.06B | 86.15% |
| 2024-06-30 | $0.04B | $0.04B | 85.37% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.740B | $0.065B |
| CeriBell Inc. is a commercial-stage medical technology company. It focused on transforming the diagnosis and management of patients with serious neurological conditions. The company is an AI-powered, rapidly deployable point-of-care electroencephalography platform designed to address the unmet needs of patients in the acute care setting. CeriBell Inc. is based in Sunnyvale, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $193.832B | 21.65 |
| EssilorLuxottica (ESLOY) | France | $143.666B | 0.00 |
| Stryker (SYK) | United States | $140.007B | 26.84 |
| Medtronic (MDT) | Ireland | $129.330B | 17.92 |
| Boston Scientific (BSX) | United States | $109.879B | 24.30 |
| Medline (MDLN) | United States | $58.579B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.565B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $35.845B | 17.17 |
| ResMed (RMD) | United States | $35.798B | 23.90 |
| Agilent Technologies (A) | United States | $35.321B | 22.38 |
| Koninklijke Philips (PHG) | Netherlands | $30.245B | 17.95 |
| Terumo (TRUMY) | Japan | $19.677B | 22.23 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.863B | 11.61 |
| Insulet (PODD) | United States | $16.941B | 52.58 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.096B | 0.00 |
| Baxter (BAX) | United States | $9.618B | 8.24 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.888B | 29.48 |
| Demant (WILYY) | Denmark | $6.042B | 0.00 |
| Envista Holdings (NVST) | United States | $4.731B | 23.98 |
| Lantheus Holdings (LNTH) | United States | $4.557B | 13.88 |
| BillionToOne (BLLN) | United States | $4.105B | 0.00 |
| ICU Medical (ICUI) | United States | $3.506B | 22.26 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.168B | 14.95 |
| Haemonetics (HAE) | United States | $2.679B | 11.72 |
| Neogen (NEOG) | United States | $2.345B | 51.33 |
| Phibro Animal Health (PAHC) | United States | $2.078B | 18.31 |
| Perrigo (PRGO) | Ireland | $1.979B | 4.96 |
| LeMaitre Vascular (LMAT) | United States | $1.965B | 39.54 |
| Curaleaf Holdings (CURLF) | Canada | $1.615B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.612B | 11.20 |
| Kestra Medical Technologies (KMTS) | United States | $1.602B | 0.00 |
| AtriCure (ATRC) | United States | $1.581B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.394B | 61.09 |
| AdaptHealth (AHCO) | United States | $1.366B | 19.78 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.321B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $1.082B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.039B | 308.29 |
| InMode (INMD) | Israel | $0.906B | 9.93 |
| Tilray Brands (TLRY) | Canada | $0.873B | 0.00 |
| Valneva SE (VALN) | France | $0.863B | 0.00 |
| Omeros (OMER) | United States | $0.811B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.772B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.561B | 13.38 |
| Brainsway (BWAY) | Israel | $0.444B | 75.63 |
| Cerus (CERS) | United States | $0.417B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.410B | 0.00 |
| SNDL (SNDL) | Canada | $0.386B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.380B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.347B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.328B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.310B | 24.73 |
| Evolus (EOLS) | United States | $0.277B | 0.00 |
| Quanterix (QTRX) | United States | $0.275B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.238B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanuwave Health (SNWV) | United States | $0.210B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.204B | 18.31 |
| High Tide (HITI) | Canada | $0.203B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.201B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.190B | 56.00 |
| Accendra Health (ACH) | United States | $0.176B | 1.77 |
| Vireo Growth (VREOF) | United States | $0.173B | 0.00 |
| Organigram Global (OGI) | Canada | $0.173B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.173B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.169B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.146B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.133B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.126B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.70 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.097B | 0.00 |
| Biote (BTMD) | United States | $0.095B | 4.18 |
| Exagen (XGN) | United States | $0.073B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.46 |
| Sharps Technology (STSS) | United States | $0.048B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.040B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 28.92 |
| Cytosorbents (CTSO) | United States | $0.040B | 0.00 |
| Veru (VERU) | United States | $0.036B | 0.00 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 15.33 |
| Jin Medical (ZJYL) | China | $0.023B | 0.00 |
| Bonk (BNKK) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| INLIF (INLF) | China | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |